MADISON — A collaboration between the University of Wisconsin–Madison and vaccine companies could yield a potential COVID-19 vaccine by the end of the year.
FluGen, Bharat Biotech, along with UW-Madison virologists, has begun the development and testing of a vaccine against COVID-19 called CoroFlu.
Developing and testing will take at least three to six months.
CoroFlu could be in human clinical trials by the fall of 2020.
- Coronavirus in Wisconsin: Live Updates From Across the State
- We're Open: These Restaurants Are Still Offering Carryout And Delivery
- FULL COVERAGE: Coronavirus News And Resources You Can Use
Bharat Biotech has commercialized 16 vaccines, including a vaccine developed against the H1N1 flu that caused the 2009 H1N1 pandemic.
“The partners in this endeavor, University of Wisconsin researchers, a biotech startup, and an international vaccine developer, are moving forward with a sense of urgency and integrity incumbent upon us as scientists and world citizens.” says Erik Iverson, CEO of WARF (Wisconsin Alumni Research Foundation) in a press release.
To learn more, click here.